Evidence map›Paper›PMID 27449092›Full record

ArticleOncotarget2016

Short-term pyrrolidine dithiocarbamate administration attenuates cachexia-induced alterations to muscle and liver in ApcMin/+ mice.

Aditi A Narsale, Melissa J Puppa, Justin P Hardee, Brandon N VanderVeen, Reilly T Enos, E Angela Murphy, James A Carson

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 31 citations in OpenAlex.

  1. The effects of tissue inflammation on cancer cachexia.Biochimica et biophysica acta. Molecular basis of disease · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Cancer cachexia in a mouse model of oxidative stress.Journal of cachexia, sarcopenia and muscle · 2020
    Article
  7. Article
  8. Article
  9. Article
  10. Hepatic alterations during the development and progression of cancer cachexia.Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme · 2020
    Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Role of gp130 in basal and exercise-trained skeletal muscle mitochondrial quality control.Journal of applied physiology (Bethesda, Md. : 1985) · 2018
    Article
  18. Article
  19. Skeletal muscle function during the progression of cancer cachexia in the male ApcJournal of applied physiology (Bethesda, Md. : 1985) · 2018
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Aditi A NarsaleDepartment of Exercise Science, University of South Carolina, Columbia, South Carolina, USA.
Melissa J PuppaDepartment of Exercise Science, University of South Carolina, Columbia, South Carolina, USA.
Justin P HardeeDepartment of Exercise Science, University of South Carolina, Columbia, South Carolina, USA.
Brandon N VanderVeenDepartment of Exercise Science, University of South Carolina, Columbia, South Carolina, USA.
Reilly T EnosDepartment of Pathology, Microbiology & Immunology, School of Medicine, University of South Carolina, Columbia, South Carolina, USA.
E Angela MurphyDepartment of Pathology, Microbiology & Immunology, School of Medicine, University of South Carolina, Columbia, South Carolina, USA.
James A CarsonDepartment of Exercise Science, University of South Carolina, Columbia, South Carolina, USA.
University of South Carolina · US

Funding

TISSUE BIOREPOSITORY COREP30GM103336 · NIGMS · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI BERGER, FRANKLIN G. · 2013 to 2017
$5.4M
Cachexia in ApcMin/+ mice: The role of IL-6R01CA121249 · NCI · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI CARSON, JAMES A · 2008 to 2018
$2.7M
Regulation of Macrophages in Obesity-Enhanced Colon Cancer:Benefits of QuercetinK01AT007824 · NCCIH · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI MURPHY, ELIZABETH ANGELA · 2013 to 2017
$632k
NCCIH NIH HHS K01 AT007824NCI NIH HHS R01 CA121249NIGMS NIH HHS P30 GM103336
6 · The paper itself

Abstract

Cancer cachexia is a complex wasting condition characterized by chronic inflammation, disrupted energy metabolism, and severe muscle wasting. While evidence in pre-clinical cancer cachexia models have determined that different systemic inflammatory inhibitors can attenuate several characteristics of cachexia, there is a limited understanding of their effects after cachexia has developed, and whether short-term administration is sufficient to reverse cachexia-induced signaling in distinctive target tissues. Pyrrolidine dithiocarbamate (PDTC) is a thiol compound having anti-inflammatory and antioxidant properties which can inhibit STAT3 and nuclear factor κB (NF-κB) signaling in mice. This study examined the effect of short-term PDTC administration to ApcMin/+ mice on cachexia-induced disruption of skeletal muscle protein turnover and liver metabolic function. At 16 weeks of age ApcMin/+ mice initiating cachexia (7% BW loss) were administered PDTC (10mg/kg bw/d) for 2 weeks. Control ApcMin/+ mice continued to lose body weight during the treatment period, while mice receiving PDTC had no further body weight decrease. PDTC had no effect on either intestinal tumor burden or circulating IL-6. In muscle, PDTC rescued signaling disrupting protein turnover regulation. PDTC suppressed the cachexia induction of STAT3, increased mTORC1 signaling and protein synthesis, and suppressed the induction of Atrogin-1 protein expression. Related to cachectic liver metabolic function, PDTC treatment attenuated glycogen and lipid content depletion independent to the activation of STAT3 and mTORC1 signaling. Overall, these results demonstrate short-term PDTC treatment to cachectic mice attenuated cancer-induced disruptions to muscle and liver signaling, and these changes were independent to altered tumor burden and circulating IL-6.

Indexed as

Adenomatous Polyposis Coli ProteinAnimalsCachexiaCell Line, TumorDisease Models, AnimalHumansLipid MetabolismLiverMiceMice, Mutant StrainsMuscle, SkeletalNeoplasms, ExperimentalPyrrolidinesSignal TransductionSTAT3 Transcription FactorThiocarbamatesAdenomatous Polyposis Coli Proteinadenomatous polyposis coli protein, mousepyrrolidine dithiocarbamic acidPyrrolidinesSTAT3 Transcription FactorThiocarbamateshepatomegalyinflammationmetabolismmuscle atrophyprotein turnover

Identifiers

PMID27449092
PMCPMC5312326
OpenAlexW2505640316

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.